by
Lauren Dubinsky, Senior Reporter | January 04, 2017
Courtesy of
Advanced Oncotherapy
Advanced Oncotherapy announced that it has made further progress in the development of its Linac Image Guided Hadron Technology, or LIGHT. The proton source is now integrated with the Radio Frequency Quadruple after a successful testing program in Geneva, Switzerland.
LIGHT can accelerate protons to the same energy level as legacy machines, but in a system that's a quarter of the size and up to a fifth of the cost. It can also deliver proton beams with great precision than older technologies.
The testing program demonstrated that there is predicted acceleration of the proton beam through the RFQ and that the measurements are the same as those from computer simulations.

Ad Statistics
Times Displayed: 45539
Times Visited: 1299 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
Advanced Oncotherapy's Professor Steve Myers believes that it's important to design and build an RFQ with higher frequency and short we wavelength as well as smaller dimensions than other linear accelerators.
Paul Collier, head of the beams department at the European Organization for Nuclear Research, said in a video that the high frequency RFQ is "the most beautiful piece of equipment" that he has been involved in manufacturing.
"This is a very important piece of technology transfer from CERN to the outside world," he added. "We were challenged to design and build the world's highest frequency and highest power RFQ."
In July 2015, Advanced Oncotherapy
predicted that the first patient will be treated with LIGHT in 2017. The company expects to compete in the compact proton therapy segment and has
signed a purchase agreement with Sinophi Healthcare Limited in East China.